NET INCOME (LOSS) PER SHARE - Narrative (Details)	May 20, 2020 shares
Zyla Life Sciences \| Warrants
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Purchase price, number of shares outstanding (in shares)	12,430,913

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_EarningsPerShareBasicLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration